What is the address of Dr. Bernard Schockaert?

The registered office of Dr. Bernard Schockaert is located at Grote Thems 53, 8490 Jabbeke.

Is Dr. Bernard Schockaert still active?

Yes. According to the CBE (16 September 2026) Dr. Bernard Schockaert is active, legal situation “Normale toestand”, started on 5 October 2021.

Is Dr. Bernard Schockaert registered on Peppol?

Yes, Dr. Bernard Schockaert is registered on the Peppol network with ID 0208:0775299719.

What is the enterprise number of Dr. Bernard Schockaert?

The enterprise number of Dr. Bernard Schockaert is BE0775299719.

When was Dr. Bernard Schockaert founded?

Dr. Bernard Schockaert was founded on 5 October 2021.

Who are the directors of Dr. Bernard Schockaert?

According to the 2025 annual accounts, the directors of Dr. Bernard Schockaert are: Bernard Schockaert.

Is Dr. Bernard Schockaert a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 October 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Bernard Schockaert make in 2025?

Dr. Bernard Schockaert posted a profit after taxes of € 464,296 in financial year 2025.

What is the revenue of Dr. Bernard Schockaert?

As a small company, Dr. Bernard Schockaert is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 625,806.

Dr. Bernard Schockaert (Private Limited) - Jabbeke

Dossier Dr. Bernard Schockaert, printed on 16 September 2026 from databakkes.be/en/0775299719/dr-bernard-schockaert. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 23 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Bernard Schockaert from Jabbeke, company number BE0775299719, closed financial year 2025 with a result of € 464,296 after tax. For that financial year Dr. Bernard Schockaert recorded a gross margin of € 625,806 and equity of € 48,894. Compared with financial year 2024, the result moved from € 240,483 to € 464,296. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Healthy

€ 48,894

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 464,296

▲ 93% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 18,953

▼ 69% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 464,296 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 14,802

▼ 40% vs 2024

Of which on lease € 12,982.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 4,792

▼ 70% vs 2024

€ 2,798 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 5,378

▲ € 4,393 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 27,951

▲ € 26,266 vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 104,714 Gross margin 2022: € 104,714 First fiscal year in the series	€ 197,390 Gross margin 2023: € 197,390 ▲ 89% vs 2022 (€ 104,714) Favourable step	€ 323,519 Gross margin 2024: € 323,519 ▲ 64% vs 2023 (€ 197,390) Favourable step	€ 625,806 Gross margin 2025: € 625,806 ▲ 93% vs 2024 (€ 323,519) Favourable step	▲ 93%
Profit after taxes	€ 70,604 Profit after taxes 2022: € 70,604 First fiscal year in the series	€ 141,265 Profit after taxes 2023: € 141,265 ▲ 100% vs 2022 (€ 70,604) Favourable step	€ 240,483 Profit after taxes 2024: € 240,483 ▲ 70% vs 2023 (€ 141,265) Favourable step	€ 464,296 Profit after taxes 2025: € 464,296 ▲ 93% vs 2024 (€ 240,483) Favourable step	▲ 93%
Equity	€ 85,458 Equity 2022: € 85,458 First fiscal year in the series	€ 226,723 Equity 2023: € 226,723 ▲ 165% vs 2022 (€ 85,458) Favourable step	€ 48,894 Equity 2024: € 48,894 ▼ 78% vs 2023 (€ 226,723) Unfavourable step	€ 48,894 Equity 2025: € 48,894 Unchanged (€ 48,894) Unchanged
Total debts	€ 44,693 Total debts 2022: € 44,693 First fiscal year in the series	€ 31,280 Total debts 2023: € 31,280 ▼ 30% vs 2022 (€ 44,693) Favourable step	€ 261,062 Total debts 2024: € 261,062 ▲ € 229,782 vs 2023 (€ 31,280) Unfavourable step	€ 281,079 Total debts 2025: € 281,079 ▲ 8% vs 2024 (€ 261,062) Unfavourable step	▲ 8%
Cash	€ 50,981 Cash 2022: € 50,981 First fiscal year in the series	€ 62,247 Cash 2023: € 62,247 ▲ 22% vs 2022 (€ 50,981) Favourable step	€ 60,384 Cash 2024: € 60,384 ▼ 3% vs 2023 (€ 62,247) Unfavourable step	€ 18,953 Cash 2025: € 18,953 ▼ 69% vs 2024 (€ 60,384) Unfavourable step	▼ 69%
Retained profit	€ 83,458 Retained profit 2022: € 83,458 First fiscal year in the series	€ 224,723 Retained profit 2023: € 224,723 ▲ 169% vs 2022 (€ 83,458) Favourable step	€ 46,894 Retained profit 2024: € 46,894 ▼ 79% vs 2023 (€ 224,723) Unfavourable step	€ 46,894 Retained profit 2025: € 46,894 Unchanged (€ 46,894) Unchanged
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 800) Unchanged	€ 418,313 Dividend 2024: € 418,313 Unchanged (€ 0) Unchanged	€ 464,296 Dividend 2025: € 464,296 ▲ 11% vs 2024 (€ 418,313) Unchanged	▲ 11%
Bank debt	€ 37,732 Bank debt 2022: € 37,732 First fiscal year in the series	€ 26,881 Bank debt 2023: € 26,881 ▼ 29% vs 2022 (€ 37,732) Favourable step	€ 15,901 Bank debt 2024: € 15,901 ▼ 41% vs 2023 (€ 26,881) Favourable step	€ 4,792 Bank debt 2025: € 4,792 ▼ 70% vs 2024 (€ 15,901) Favourable step	▼ 70%
Balance sheet total	€ 130,151 Balance sheet total 2022: € 130,151 First fiscal year in the series	€ 258,003 Balance sheet total 2023: € 258,003 ▲ 98% vs 2022 (€ 130,151) Unchanged	€ 309,956 Balance sheet total 2024: € 309,956 ▲ 20% vs 2023 (€ 258,003) Unchanged	€ 329,974 Balance sheet total 2025: € 329,974 ▲ 6% vs 2024 (€ 309,956) Unchanged	▲ 6%

Key figures of Dr. Bernard Schockaert, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Bernard Schockaert?

What happened at Dr. Bernard Schockaert in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 464,296 (▲ 93% vs 2024). Source: NBB ↗
Oct 5, 2021 New establishment in Jabbeke. KBO
2021 Bernard Schockaert became a director. NBB
Oct 5, 2021 Start of the company according to the CBE. KBO

In short

From € 70,604 profit in 2022 to € 464,296 profit in 2025.

Paid € 291,338 in corporate taxes since 2022.

Best year ever: 2025, with € 464,296 profit.

Paid out € 883,408 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Bernard Schockaert? We notify you, reason included.

Follow Dr. Bernard Schockaert

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Bernard Schockaert

Dr. Bernard Schockaert

Anesthesie-Reanimatie AZ Delta 2.4%

Behind Dr. Bernard Schockaert is Bernard Schockaert. It owns 2.4% of Anesthesie-Reanimatie AZ Delta itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Bernard Schockaert

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Grote Thems 53

8490 Jabbeke

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0775.299.719
VAT number: BE 0775.299.719
Registered office: Grote Thems 53, 8490 Jabbeke
Names & denominations: Dr. Bernard Schockaert
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 October 2021
Peppol: Active · Active since 16 Oct 2025
Contact: [email protected]

View on CBE Public ↗ Annual accounts (NBB) ↗